Sort
46,585 grants matching “heart failure”
Using Molecular Pathology to Predict Response in Heart Failure
$749,948Brian D Lowes · University Of Colorado Denver · P20 · FY2010 · HL
Mechanistic Insights to A Translatable Therapy for Acute Reperfused Hemorrhagic Myocardial Infarctions
$749,944Rohan Dharmakumar · Indiana University Indianapolis · R01 · FY2023 · HL
Development of a pediatric transcatheter pulmonary valve system
$749,934Thuy M Pham · Sutra Medical, Inc. · R44 · FY2017 · HL
Clinical resting state fMRI software for surgical planning
$749,900Timothy Olsen · Radiologics, Inc. · R44 · FY2017 · GM
Predictive multiscale in silico cardio-pharmacology
$749,824Colleen E Clancy · University Of California At Davis · U01 · FY2017 · HL
Risk Alleles in Protein Quality Control Genes as Modifiers of Hypertrophic Cardiomyopathy
$749,824Sharlene M Day · University Of Pennsylvania · R01 · FY2024 · HL
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
$749,786Arjun Deb · University Of California Los Angeles · R01 · FY2023 · HL
Targeting Dysregulated Maturation Program in PSC-Cardiomyocytes
$749,769Chulan Kwon · Johns Hopkins University · R01 · FY2025 · HL
Targeting Dysregulated Maturation Program in PSC-Cardiomyocytes
$749,769Chulan Kwon · Johns Hopkins University · R01 · FY2024 · HL
Biosynthetic Pathways in Cardiac Remodeling
$749,757Bradford Guy Hill · University Of Louisville · R01 · FY2021 · HL
Biosynthetic Pathways in Cardiac Remodeling
$749,757Bradford Guy Hill · University Of Louisville · R01 · FY2020 · HL
Case-Management & Environmental Support to Sustain Weight Loss & Reduce CHD Risk
$749,749Randall Scott Stafford · Stanford University · R01 · FY2009 · HL
Mechanistic Studies of NAD+/NADH in Human Heart Failure
$749,718Kevin D. O'Brien · University Of Washington · R01 · FY2023 · HL
Active Bottle for Home Care of Dysphagic Infants - Phase II
$749,661Jonathan Lawrence Portny · Infoscitex Corporation · R44 · FY2008 · HD
Minimally Invasive Ventricular Polymeric Injection for Treatment of Heart Failure
$749,658Julius Matteo Guccione · Northern California Institute/Res/Edu · R01 · FY2014 · HL
Immunopathogenesis of HIV-associated pulmonary hypertension
$749,651Karen A Norris · University Of Georgia · R01 · FY2016 · HL
Leveraging advanced clinical phenotyping to enhance problem lists and support value-based healthcare
$749,614Daniel Jay Riskin · Verantos, Inc. · R44 · FY2019 · TR
Animal Models for Studying the Genetics of Hypertension
$749,605Nobuyo Maeda · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HL
p16 Cellular Senescence and Vascular Dysfunction in Sleep Apnea
$749,508Rene Gabriel Cortese · University Of Kansas Medical Center · R01 · FY2025 · HL
REMATCH TRIAL
$749,502Columbia University Health Sciences · U01 · FY2001 · HL
HIV Status and Incidence and Outcomes of Heart Failure
$749,492Michael J Silverberg · Kaiser Foundation Research Institute · R01 · FY2017 · HL
The novel role of beta3 integrin in regulating alloimmunity
$749,489Reza Abdi · Brigham And Women'S Hospital · R01 · FY2024 · AI
Redox Modification of the Arrhythmic Substrate in Heart Failure
$749,437Raimond Lester Winslow · Johns Hopkins University · R01 · FY2012 · HL
Spatial Resynchronization Therapy for AFib
$749,419Graydon Ernest Beatty · Maxwell Biomedical Inc · R44 · FY2024 · HL
Patterns of Cardiopulmonary health across the life course
$749,412Sadiya Sana Khan · Northwestern University At Chicago · R01 · FY2022 · HL